ASMB · NASDAQ · Biotechnology

Assembly Biosciences (ASMB)

Develops antiviral and liver-disease candidates through discovery and clinical development.

$25.45
After hours−0.02 (−0.08%)
At close$25.47(+0.12%)
  1. Best Momentum Stocks to Buy for September 17th

    Zacks Investment Research

  2. New Strong Buy Stocks for September 17th

    Zacks Investment Research